Long-term stability of coagulation variables: Protein S as a biomarker for preanalytical storage-related variations in human plasma

• References

• 1 ISBER Best Practices for Repositories: Collection, Storage and Retrieval of Biological Materials for Research. 2007 edition.
• 2 Betsou F, Luzergues A, Carter A. et al. Towards norms for accreditation of biobanks for human health and medical research: compilation of existing guidelines into an ISO certification/accreditation norm-compatible format. Quality Ass J 2007; 11: 221-294.
• 3 Carraro P, Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem 2007; 53: 1338-1342.
• 4 NCCLS Procedures for the handling and processing of blood specimens. Approved Guideline-Third Edition. NCCLS document H18-A3
• 5 Riegman PHJ, Morente MM, Betsou F. et al. and the Marble Arch International Working Group on Biobanking for Biomedical Research. Biobanking for better healthcare. Mol. Oncology 2008; 2: 213-222.
• 6 Devanapalli B, Bermingham MA, Mahajan D. Effect of long-term storage at –80°C on the various lipid parameters in stored plasma samples. Clin Chim Acta 2002; 322: 179-181.
• 7 Woodhams B, Girardot O, Blanco MJ. et al. Stability of coagulation proteins in frozen plasma. Blood Coag Fibrinolysis 2001; 12: 229-236.
• 8 Dzik WH, Riibner MA, Linehan SK. Refreezing previously thawed fresh-frozen plasma. Stability of coagulation factors V and VIII:C. Transfusion 1989; 29: 600-604.
• 9 McLellan DC, Pelly C, McLellan HG, Aronstam A. The stability of VIII:C in frozen stored plasma samples re-examined. Clin Lab Haematol 1983; 5: 197-201.
• 10 Milam JD, Buzzurro CJ, Austin SF, Stansberry SW. Stability of factors V and VIII in thawed fresh frozen plasma units. Transfusion 1980; 20: 546-548.
• 11 Sward-Nilsson AM, Persson PO, Johnson U, Lethagen S. Factors influencing factor VIII activity in frozen plasma. Vox Sang 2006; 90: 33-39.
• 12 Van de Poel RHL, Meijers JCM, Bouma BN. Interaction between Protein S and Complement C4b-binding protein (C4BP). J Biol Chem 1999; 274: 15144-15150.
• 13 Rock GA, Tackaberry ES, Palmer DS. Factors affecting the relative distribution of high and low molecular weight forms of factor VIII. Thromb Res 1979; 14: 573-587.
• 14 Sere KM, Janssen MP, Willems GM, Tans G, Rosing J, Hackeng TM. Purified protein S contains multi-meric forms with increased APC-independent anticoagulant activity. Biochemistry 2001; 40: 8852-8860.
• 15 Wang W, Wang YJ, Kelner DN. Coagulation factor VIII: structure and stability. Int J Pharmaceutics 2003; 259: 1-15.
• 16 Gale AJ, Cramer TJ, Rozenshteyn D, Cruz JR. Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V. J Biol Chem 2008; 283: 16355-62.
• 17 Dahlback B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61.
• 18 Luddington R, Peters J, Baker P, Baglin T. The effect of delayed analysis or freeze-thawing on the measurement of natural anticoagulants, resistance to activated protein C and markers of activation of the haemostatic system. Thromb Res 1997; 6: 577-581.
• 19 Zürcher M, Sulzer I, Barizzi G. et al. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost 2008; 99: 416-426.
• 20 Lane DA, Mannucci PM, Bauer KA. et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-662.
• 21 Lengellé J, Panopoulos E, Betsou F. Soluble CD40-Ligand as a biomarker for storage-related pre-analytic variations of human serum. Cytokine 2008; 44: 275-282.
• 22 Buhler R, Hovinga JK, Aebi-Huber I. et al. Improved detection of proteolytically cleaved high molecular weight kininogen bu immunoblotting using an antiserum against its reduced 47 kDa light chain. Blood Coagul Fibrinolysis 1995; 6: 223-232.